Tagged: Delayed Adverse Reactions

2

Fluoroquinolones, FDA Memo Highlights Damning Evidence

Recently an internal memo dated April 17, 2013, issued by the Food and Drug Administration’s Center Drug Evaluation and Research, Office of Surveillance and Epidemiology, was obtained through the freedom of information act shows the FQs in a damning light.